» Articles » PMID: 18753135

A Phospholipid Substrate Molecule Residing in the Membrane Surface Mediates Opening of the Lid Region in Group IVA Cytosolic Phospholipase A2

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2008 Aug 30
PMID 18753135
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The Group IVA (GIVA) phospholipase A(2) associates with natural membranes in response to an increase in intracellular Ca(2+) along with increases in certain lipid mediators. This enzyme associates with the membrane surface as well as binding a single phospholipid molecule in the active site for catalysis. Employing deuterium exchange mass spectrometry, we have identified the regions of the protein binding the lipid surface and conformational changes upon a single phospholipid binding in the absence of a lipid surface. Experiments were carried out using natural palmitoyl arachidonyl phosphatidylcholine vesicles with the intact GIVA enzyme as well as the isolated C2 and catalytic domains. Lipid binding produced changes in deuterium exchange in eight different regions of the protein. The regions with decreased exchange included Ca(2+) binding loop one, which has been proposed to penetrate the membrane surface, and a charged patch of residues, which may be important in interacting with the polar head groups of phospholipids. The regions with an increase in exchange are all located either in the hydrophobic core underneath the lid region or near the lid and hinge regions from 403 to 457. Using the GIVA phospholipase A(2) irreversible inhibitor methyl-arachidonyl fluorophosphonate, we were able to isolate structural changes caused only by pseudo-substrate binding. This produced results that were very similar to natural lipid binding in the presence of a lipid interface with the exception of the C2 domain and region 466-470. This implies that most of the changes seen in the catalytic domain are due to a substrate-mediated, not interface-mediated, lid opening, which exposes the active site to water. Finally experiments carried out with inhibitor plus phospholipid vesicles showed decreases at the C2 domain as well as charged residues on the putative membrane binding surface of the catalytic domain revealing the binding sites of the enzyme to the lipid surface.

Citing Articles

Regulatory mechanisms triggered by enzyme interactions with lipid membrane surfaces.

Yu J, Boehr D Front Mol Biosci. 2023; 10:1306483.

PMID: 38099197 PMC: 10720463. DOI: 10.3389/fmolb.2023.1306483.


The Phospholipase A2 Superfamily: Structure, Isozymes, Catalysis, Physiologic and Pathologic Roles.

Khan S, Ilies M Int J Mol Sci. 2023; 24(2).

PMID: 36674864 PMC: 9862071. DOI: 10.3390/ijms24021353.


Membrane Association Allosterically Regulates Phospholipase A Enzymes and Their Specificity.

Mouchlis V, Dennis E Acc Chem Res. 2022; 55(23):3303-3311.

PMID: 36315840 PMC: 9730854. DOI: 10.1021/acs.accounts.2c00497.


Vitamin E functions by association with a novel binding site on the 67 kDa laminin receptor activating diacylglycerol kinase.

Hayashi D, Mouchlis V, Okamoto S, Namba T, Wang L, Li S J Nutr Biochem. 2022; 110:109129.

PMID: 35977663 PMC: 10243646. DOI: 10.1016/j.jnutbio.2022.109129.


Unraveling cardiolipin-induced conformational change of cytochrome c through H/D exchange mass spectrometry and quartz crystal microbalance.

Sun S, Huang H, Lo Y, Chuang M, Hsu Y Sci Rep. 2021; 11(1):1090.

PMID: 33441668 PMC: 7806790. DOI: 10.1038/s41598-020-79905-8.


References
1.
Evans J, Leslie C . The cytosolic phospholipase A2 catalytic domain modulates association and residence time at Golgi membranes. J Biol Chem. 2003; 279(7):6005-16. DOI: 10.1074/jbc.M311246200. View

2.
Mosior M, Six D, Dennis E . Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity. J Biol Chem. 1998; 273(4):2184-91. DOI: 10.1074/jbc.273.4.2184. View

3.
Roussel A, Miled N, Berti-Dupuis L, Riviere M, Spinelli S, Berna P . Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor. J Biol Chem. 2001; 277(3):2266-74. DOI: 10.1074/jbc.M109484200. View

4.
Funk C . Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001; 294(5548):1871-5. DOI: 10.1126/science.294.5548.1871. View

5.
Mandell J, Falick A, Komives E . Identification of protein-protein interfaces by decreased amide proton solvent accessibility. Proc Natl Acad Sci U S A. 1998; 95(25):14705-10. PMC: 24513. DOI: 10.1073/pnas.95.25.14705. View